A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: Effect on prolongation of survival and improvement of quality of life

Hepato-Gastroenterology

Volumn 46, Issue 28, 1999, Pages 2662-2668

  Nakano, Hiroshi ^a   Namatame, Kimio ^a   Nemoto, Hiroshi ^a   Motohashi, Hisahiko ^b   Nishiyama, Kiyoshi ^c   Kumada, Kaoru ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c YOKOHAMA NATIONAL UNIVERSITY   (Japan)

Author keywords

Cisplatin; Lentinan; Quality of life; Survival analysis; Tegafur; Unresectable and recurrent gastric cancer

Indexed keywords

CISPLATIN; LENTINAN; TEGAFUR;

ADULT; AGED; APPETITE; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT CANCER; SLEEP; STOMACH CANCER; SURVIVAL RATE;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; HUMANS; LENTINAN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR;

EID: 0032830873     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hamuro J, Maeda YY, Arai Y, Fukuoka F: Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (an edible mushroom), Cancer Res 1970; 30:2776-2781.
2. Maeda Y, Chihara G: The effects of neonatal thymectomy on the antitumor activity of lentinan, carboxymethyl-pachymaran and zymosan, and their effects on various immune responses. Int J Cancer 1973; 11:153-161.
3. Suga T, Shiio T, Maeda Y, Chihara G: Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effects on 3-methylcholanthrene-induced carcinogenesis. Cancer Res 1984; 44:5132-5137.
4. Suzuki M, Higuchi S, Taki S, Miwa K, Hamuro J: induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2. Int J Immunopharm 1990; 12:613-619.
5. Herlyn D, Kaneko Y, Powe J, Aoki T, Koprowski H: Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan. Jpn J Cancer Res (Gann) 1985; 76:37-42.
6. Masuko Y, Nakajima H, Tsubouchi J, Yamazaki M, Mizuno D, Abe S: Changes of antitumor immunity of hosts with murine mammary tumors regressed by lentinan: potentiation of antitumor delayed hypersensitivity reaction. Jpn J Cancer Res (Gann) 1982; 73:790-797.
7. Ladanyi A, Timar J, Lapis K: Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Immunol Immunother 1993; 36:123-126.
8. Taguchi T: Clinical efficacy of lentinan on patients with stomach cancer. Cancer Detect Prev 1987; Suppl 1:333-349.
9. Skeel RT, Ganz PA: Systemic assessment of patients with cancer and tong-term medical complications of treatment. In: Skeel RT, Lachant NA (Eds.). Handbook of cancer chemotherapy, 4th Edition. Boston: Little, Brown and Company, 1995; pp. 95-115.
10. Japanese Research Society for Gastric Cancer: Japanese classification of gastric carcinoma. The first English edition. Kanehara, Tokyo 1995; pp. 1-104.
11. Hisashi F: Quality of life in patients with advanced cancer. Jpn J Cancer Chemotherapy 1987; 14:1-10.
12. Suzuki M, Takatsuki M, Maeda YY, Hamuro J, Chihara G: Anti-tumor and immunological activity of lentinan in comparison with LPS. Int J Immonopharmacol 1994; 16:462-468.
13. Hamuro J: Lentinan regulates the local inflammatory cellular reaction at tumor tissues: Its relation with antitumor effects. Biotherapy 1996; 10:581-588. (In Japanese with English abstract)
14. Hamuro J, Shimamura T, Suzuki M: Proposals for new cancer immunotherapy using lentinan and IL-2, Biotherapy 1996; 10:72-82. (In Japanese with EngLish abstract)
15. Hamuro J, Kikuchi T, Takatsuki F, Suzuki M: Cancer cell progression and chemoimmunotherapy - Dual effects in the induction of resistance to therapy. Br J Cancer 1996; 73:465-471.
16. Aou S, Ma J, Hori T: Effects of lentinan on food intake and plasma calcium level. Biotherapy 1991; 5:1728-1731. (In Japanese with English abstract)
17. Watanabe T, Ogawa K: Study on pre-operative intratumor administration of lentinan for gastric cancer cases: II. Antitumor immune response of regional lymph nodes. J Jpn Soc Cancer Ther 1995; 30:948-955.
18. Strassmann G, Masui Y, Chizzonite R, Fong M: Mechanisms of experimental cancer cachexia: Local involvement of IL-1 in colon-26 tumor. J Immunol 1993; 150:2341-2345.